Holen Sie sich die Stockscreener-App
1.095
9.50%
-0.115
Vorhandelsmarkt:
1.18
0.085
+7.76%
Schlusskurs vom Vortag:
$1.21
Offen:
$1.19
24-Stunden-Volumen:
504.56K
Relative Volume:
0.62
Marktkapitalisierung:
$80.58M
Einnahmen:
$311.14M
Nettoeinkommen (Verlust:
$-177.97M
KGV:
-0.4323
EPS:
-2.5329
Netto-Cashflow:
$-20.82M
1W Leistung:
-6.41%
1M Leistung:
-36.71%
6M Leistung:
-61.71%
1J Leistung:
-75.45%
1-Tages-Spanne:
$1.08
$1.205
1-Wochen-Bereich:
$1.04
$1.29
52-Wochen-Spanne:
$1.04
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.095 | 80.58M | 311.14M | -177.97M | -20.82M | -2.5329 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Health Catalyst, Asure Software, GitLab, Zeta Global, and SoundHound AI Shares Plummet, What You Need To Know - TradingView
Health Catalyst downgraded at Wells Fargo after Q4 results - MSN
Health Catalyst, Inc. (HCAT) cut to equal weight at Wells Fargo on prolonged revenue, margin pressure - MSN
Health Catalyst (HCAT) Q4 2025 Earnings Transcript - AOL.com
If You Invested $1,000 in Health Catalyst (HCAT) - Stock Titan
Health Catalyst, Inc. (HCAT) Cut to Equal Weight at Wells Fargo on Prolonged Revenue, Margin Pressure - Yahoo Finance
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst (HCAT) Stock Trades Down, Here Is Why - Yahoo Finance
Health Catalyst, IncCommon stock (NQ: HCAT - The Chronicle-Journal
Wells Fargo Adjusts Outlook for Health Catalyst (HCAT) - GuruFocus
Health Catalyst stock downgraded at Wells Fargo (HCAT:NASDAQ) - Seeking Alpha
Total debt per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
HCAT Downgraded: Wells Fargo Lowers Price Target by 80% | HCAT S - GuruFocus
Health Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from Wells Fargo & Company - MarketBeat
Health Catalyst Q4 2025 Earnings: Revenue Exceeds Forecasts, Margins DeclineNews and Statistics - IndexBox
Wells Fargo Downgrades Health Catalyst to Equalweight From Overweight, Adjusts PT to $1 From $5 - marketscreener.com
Wells Fargo downgrades Health Catalyst stock rating on structural concerns By Investing.com - Investing.com India
Wells Fargo downgrades Health Catalyst stock rating on structural concerns - Investing.com
Wells Fargo downgrades Health Catalyst (HCAT) - MSN
HCAT Q4 Deep Dive: Margin Focus and Strategic Review Amid Platform Migration Pressures - Yahoo Finance
Health Catalyst 2025 Results & 2026 Outlook: Ignite Platform & Growth StrategyNews and Statistics - IndexBox
Health Catalyst (HCAT) Receives a Hold from Stephens - The Globe and Mail
Market Recap: Is Health Catalyst Inc a top pick in the sector2026 Retail & Reliable Trade Execution Plans - baoquankhu1.vn
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 18.1% in February - MarketBeat
Health Catalyst Sees Increased Investment from First Light Asset Management - National Today
Health Catalyst, Inc. $HCAT is First Light Asset Management LLC's 7th Largest Position - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Net current asset value per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT) - The Globe and Mail
Canaccord Genuity Keeps Their Buy Rating on Health Catalyst (HCAT) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail
Cantor Fitzgerald Keeps Their Hold Rating on Health Catalyst (HCAT) - The Globe and Mail
Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative - simplywall.st
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $1.75 - MarketBeat
Health Catalyst (HCAT) Shares Plummet After Mixed Q4 Results - GuruFocus
Health Catalyst (HCAT) Receives Analyst Rating Update from Steph - GuruFocus
HCAT: Canaccord Genuity Lowers Price Target But Maintains Buy Ra - GuruFocus
Health Catalyst (NASDAQ:HCAT) Given New $2.00 Price Target at Stephens - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review - Seeking Alpha
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00 - MarketBeat
Canaccord cuts Health Catalyst stock price target on weak guidance - Investing.com Nigeria
Canaccord cuts Health Catalyst stock price target on weak guidance By Investing.com - Investing.com South Africa
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com South Africa
Cantor Fitzgerald cuts Health Catalyst stock price target on turnaround uncertainty - Investing.com South Africa
Health Catalyst, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Stifel cuts Health Catalyst stock price target on migration woes By Investing.com - Investing.com Australia
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):